Delivery Order SPE2DB22D3301-SPE2DB25FZ1HR
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $27,071.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Activase 50 mg vials, with an ultimate completion date of September 25, 2025. This competitively awarded contract, with no set-aside designation, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,875.45 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed-price contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $21,231.29 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,676.32 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of September 12, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, with a ceiling value of $17,807.88. This firm fixed-price contract was competitively awarded without set-aside designation and has an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,595.40 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, with an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $15,172.51 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials. This firm fixed-price contract, awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $35.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Activase 100 mg vials, with completion scheduled for September 10, 2025. The contract is unclassified as a set-aside and represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $16,632.32 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, with an ultimate completion date of August 27, 2025. The contract utilizes firm fixed price pricing and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...